Lightning Round: Sanofi, InterLinks, Ford Motor and More

CA Technologies : This application software company’s stock has no momentum, Cramer said. Go with Oracle instead.

Amarin : Although this Dublin-based drug manufacturer has no earnings or revenue to speak of, Cramer will bless this stock as a speculative buy.

McDermott International : Don’t buy this stock, Cramer said. He didn’t like that the heavy construction company recently reported a disappointing quarter.

Ford Motor : The automaker has considerable exposure to Europe and faces increasing commodity costs, making it hard for its stock to go higher any time soon. Nonetheless, Cramer wouldn’t mind owning F shares. He just doesn’t expect any upside in the near-term.

InterLinks : “What a disaster,” Cramer said of this technology company, which recently reported disappointing quarterly results. “Don’t buy.”

Sanofi : Cramer is a buyer of this drug manufacturer’s stock.










When this story was published, Cramer’s charitable trust owned Oracle and Sanofi.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com